About Gregor Diagnostics
Gregor Diagnostics is a private company based in Dallas, Texas. It has reported $14,526,411 raised in five offerings on Form D since July 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 20, 2025 | Nov 4, 2025 | $242,034of $250K target | 13 | $18,618 | EquityRule 506(b) | Form D ↗ |
| Mar 30, 2023 | Oct 31, 2023amended Dec 16, 2024 | $7,429,000of $10.0M target | 8 | $928K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 15, 2021 | Oct 29, 2021 | $5,039,710of $6.5M target | 7 | $719K | EquityRule 506(b) | Form D ↗ |
| Oct 18, 2019 | Oct 28, 2019 | $915,667of $1.1M target | 8 | $114K | EquityRule 506(b) | Form D ↗ |
| Jun 29, 2018 | Jul 12, 2018 | $900,000of $1.0M target | 11 | $81,818 | Equity, DebtRule 506(b) | Form D ↗ |
| Total, five offerings | $14,526,411 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gregor Diagnostics's Form D filed Nov 4, 2025.
GG
Gilbert Garcia
Director
MB
Mike Bress
Chief Financial Officer
LT
Lauren Tyra
Director
MP
Michael Partsch
Director
Also a director at AIQ Solutions and Atrility Medical and an executive officer and director at Nalu Medical.
Earlier filings also listed Tobias Zutz (executive officer and director, last listed Dec 2024), Sundaresh Brahmasandra (director, last listed Dec 2024) and Steven Weinstein (director, last listed Dec 2024).